Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Apr-24 5:30 PM View:  | Pham Quang X CEO and Chairman Director 10% Owner | Cadrenal Therapeutics, Inc. (CVKD) | 10-Apr-24 | Gift | 50,000 | -- | -- | (< 1%) 6.33M to 6.28M | |
| 12-Feb-24 9:41 PM View: | Pham Quang X CEO and Chairman Director 10% Owner | Cadrenal Therapeutics, Inc. (CVKD) | 23-Oct-23 | Gift | 85,000 | -- | -- | (1%) 6.41M to 6.33M | |
| 06-Oct-23 5:32 PM View: | Murphy John Raymond Director | Cadrenal Therapeutics, Inc. (CVKD) | 05-Oct-23 | Purchase | 2,669 | $0.69 | $1,841.61 | < 1% 612.12K to 614.79K | |
| 06-Oct-23 5:32 PM View: | Murphy John Raymond Director | Cadrenal Therapeutics, Inc. (CVKD) | 04-Oct-23 | Private Purchase | 17,331 | $0.70 | $12,131.70 | 3% 594.79K to 612.12K | |
| 06-Sep-23 3:28 PM View: | Pham Quang X CEO and Chairman Director 10% Owner | Cadrenal Therapeutics, Inc. (CVKD) | 05-Sep-23 | Private Purchase | 40,000 | $0.90 | $36,188.00 | < 1% 6.37M to 6.41M | |
| 05-Sep-23 6:05 AM View: | Pham Quang X CEO and Chairman Director 10% Owner | Cadrenal Therapeutics, Inc. (CVKD) | 01-Sep-23 | Private Purchase | 70,000 | $0.91 | $63,945.00 | 1% 6.3M to 6.37M | |
| 22-Mar-23 4:01 PM View: | Murphy John Raymond Director | Cadrenal Therapeutics, Inc. (CVKD) | 21-Mar-23 | Private Purchase | 10,000 | $1.39 | $13,900.00 | 2% 584.79K to 594.79K | |
| 16-Mar-23 10:00 PM View: | Murphy John Raymond Director | Cadrenal Therapeutics, Inc. (CVKD) | 16-Mar-23 | Private Purchase | 20,000 | $1.67 | $33,398.00 | 4% 554.79K to 574.79K | |
| 13-Feb-23 9:00 AM View: | Pham Quang X CEO and Chairman Director 10% Owner | Cadrenal Therapeutics, Inc. (CVKD) | 10-Feb-23 | Grant | 25,000 | $1.94 | $48,500.00 | < 1% 6.28M to 6.3M | |
| 24-Jan-23 5:01 PM View: | Szot Matthew K Chief Financial Officer | Cadrenal Therapeutics, Inc. (CVKD) | 24-Jan-23 | Grant | 50,000 | -- | -- | 11% 450.0K to 500.0K | |
| 24-Jan-23 5:00 PM View: | Murphy John Raymond Director | Cadrenal Therapeutics, Inc. (CVKD) | 24-Jan-23 | Conversion | 514,792 | -- | -- | 1287% 40.0K to 554.79K | |
| 24-Jan-23 5:02 PM View: | Wilson Glynn Director | Cadrenal Therapeutics, Inc. (CVKD) | 24-Jan-23 | Conversion | 50,000 | -- | -- | 100% 0 to 50.0K |
